Compare PAX & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAX | LKFT |
|---|---|---|
| Founded | 1988 | N/A |
| Country | Cayman Islands | Belgium |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2020 | 2007 |
| Metric | PAX | LKFT |
|---|---|---|
| Price | $11.22 | $28.73 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 182.7K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | ★ 4.81% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.99 | N/A |
| Revenue Next Year | $16.52 | N/A |
| P/E Ratio | $25.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.55 | $25.68 |
| 52 Week High | $17.80 | $30.91 |
| Indicator | PAX | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 51.83 |
| Support Level | $10.79 | $25.68 |
| Resistance Level | $11.56 | $28.68 |
| Average True Range (ATR) | 0.34 | 0.62 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 60.96 | 80.30 |
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.